METUPUK
METUPUK is a UK wide patient advocacy charity for people with metastatic breast cancer (MBC) campaigning to increase public awareness and education about MBC. We work to see better care, access to drugs and trials as well as representation of MBC patients within NHS UK, the national regulators and drug companies.
Financial health, per its FY2025 accounts
The accounts state that the charity ended the financial year with a net profit of £21,000, having exceeded its expenditure. The trustees report that the charity holds unrestricted reserves of £25,000, which meets their stated policy of holding a minimum of 12 months of running costs.
What the accounts disclose
“For the financial period, the Charity’s main source of income was donations, comprising 60% of the total funding.” — page 25
“METUPUK holds a minimum of 12 months running costs in reserve from unrestricted funds.” — page 26
Trustees
- Dr Helen Steele
- Emma Smith
- Katherine Southwell
- LAURA ASHURST
- Philip Southwell
- Sue Thomas
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/03/2025 | £58k | £36k |
| 31/03/2024 | £78k | £61k |
| 05/04/2023 | £87k | £25k |
Common questions
Is METUPUK financially healthy?
Per its FY2025 accounts: The accounts state that the charity ended the financial year with a net profit of £21,000, having exceeded its expenditure. The trustees report that the charity holds unrestricted reserves of £25,000, which meets their stated policy of holding a minimum of 12 months of running costs. Its FY2025 accounts were independently examined.